share_log

HC Wainwright & Co. Reiterates Buy on ImmunoPrecise Antibodies, Maintains $9 Price Target

HC Wainwright & Co. Reiterates Buy on ImmunoPrecise Antibodies, Maintains $9 Price Target

HC Wainwright & Co.重申買入免疫精準抗體,維持9美元的目標股價
Benzinga ·  2023/07/12 06:09

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates ImmunoPrecise Antibodies (NASDAQ:IPA) with a Buy and maintains $9 price target.

HC Wainwright&Co.分析師Swayampakula Ramakanth重申免疫精製抗體(納斯達克:IPA)的買入,並維持9美元的目標價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論